Sehresh Saleem, PhD in

Sehresh Saleem, PhD

Login to view DISC.
Longevity Biotech Fellowship-Fellow (Cohort 7, Fall 2025) at Longevity Biotech Fellowship
📍 San Francisco, California, United States

Sehresh is a biotechnology leader focused on early drug and clinical development program management. As Director at Sangamo Therapeutics, she leads an innovative gene therapy program for neuropathic pain. She holds a PhD from Texas A&M University and a certificate in AI in Pharma and Biotech from MIT Sloan.

She is passionate about advancing human health, with a strong focus on longevity and womens health. Sehresh actively engages in discussions about aging therapeutics and the momentum building in the FemTech space, seeing it as a top priority to address the challenges and opportunities in these fields.

Unique fact: She is exploring the idea that GLP-1s may be the first geroprotectives, or longevity drugs, to emerge from the pharmaceutical industry.

Read the full overview →
Experience
17 Years
Current Role
Longevity Biotech Fellowship-Fellow (Cohort 7, Fall 2025)
Job Level
Mid-senior
Location
San Francisco, California, United States
Personality Overview

How Sehresh shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Sehresh cares about

Longevity Therapeutics
Her fellowship and posts show a deep interest in targeting aging to prevent multiple diseases, questioning if GLP-1s are the first geroprotectives.
Women's Health
She is energized by the growing momentum and innovation in women's health, actively meeting with founders and catalysts in the FemTech space.
+5 more topics Login to view topics
Career

Work history

7-2025
Longevity Biotech Fellowship-Fellow (Cohort 7, Fall 2025)
Longevity Biotech Fellowship
6-2025
Director, Program Management
Sangamo Therapeutics, Inc.
10-2024 - 3-2025
Director, Program & Alliance Management
CytomX Therapeutics
8-2021 - 10-2024
Associate Director, Program Management, Clinical Development
CytomX Therapeutics
9-2017 - 8-2021
Sr. Project Manager, Pharma Services
NeoGenomics Laboratories
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2009 - 2014
Doctor of Philosophy (PhD)
Texas A&M University
AI in Pharma and Biotech
MIT Sloan School of Management
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Sehresh. Free, 10 seconds.